RBM15 deficiency decreased m6A modification of DLG3 mRNA and subsequently induced GSC proneural-to-mesenchymal transition by activating the STAT3 pathway to support glioblastoma progression and radioresistance [137]. Here, STAT3 is linked to glioblastoma.